First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval
Published on April 27, 2026 at 08:34PM by Drugs.com - Daily MedNews
MONDAY, April 27, 2026 — In a historic leap for medical science, the U.S. Food and Drug Administration (FDA) has greenlit the first-ever gene therapy to treat a rare form of inherited deafness. The treatment — called Otarmeni &mdash...
Read the original article here: https://www.drugs.com/news/first-gene-therapy-genetic-hearing-loss-otarmeni-gains-fda-approval-129807.html